Volume 22, Number 12—December 2016
CME ACTIVITY - Research
Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015
|Age, median y (IQR)||30 (20–40)|
|Ct value on diagnostic Ebola PCR, n = 84
|No. cycles, median (range)||26.8 (17.8–35.8)|
|Duration of symptoms, median d (IQR), n = 74
|Coexisting chronic medical condition||15 (17.6)|
|Selected symptoms on admission|
|Nausea and vomiting||43 (50.6)|
*Values are no. (%) patients except as indicated. Ct, cycle threshold; IQR, interquartile range.
†For example, tuberculosis, HIV, or malaria.
‡For example, diabetes mellitus, arterial hypertension, chronic cardiac, pulmonary disease, or renal disease.
Page created: November 17, 2016
Page updated: November 17, 2016
Page reviewed: November 17, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.